Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5251
CALL
ICICI Bank
IBN
$109B
| $152K | ﹤0.01% |
12,100
-15,300
| -56% | -$177K |
|
5252
PUT
Icahn Enterprises
IEP
$4.9B
| $152K | ﹤0.01% |
+2,100
| New | +$152K |
|
5253
LifeVantage
LFVN
$84.4M
| $152K | ﹤0.01% |
11,685
-75,749
| -87% | -$900K |
|
|
SYBX
5254
DELISTED
Synlogic
SYBX
| $152K | ﹤0.01% |
1,116
+362
| +48% | +$44.1K |
|
5255
ProShares UltraShort Silver
ZSL
$54.8M
| $152K | ﹤0.01% |
25
-14
| -36% | -$90.7K |
|
|
HZNP
5256
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $152K | ﹤0.01% |
6,300
-3,600
| -36% | -$91.3K |
|
5257
CALL
Century Aluminum
CENX
$4.71B
| $151K | ﹤0.01% |
21,800
+4,800
| +28% | +$35.7K |
|
5258
Hurco Companies Inc
HURC
$142M
| $151K | ﹤0.01% |
4,223
+1,599
| +61% | +$60.4K |
|
5259
CALL
iShares US Financials ETF
IYF
$4.64B
| $151K | ﹤0.01% |
2,400
| – | – |
|
5260
Kiniksa Pharmaceuticals
KNSA
$6.06B
| $151K | ﹤0.01% |
11,155
+6,790
| +156% | +$105K |
|
5261
CALL
Kontoor Brands
KTB
$4.63B
| $151K | ﹤0.01% |
+5,376
| New | +$160K |
|
|
PTN
5262
Palatin Technologies
PTN
$13.8M
| $151K | ﹤0.01% |
104
+58
| +126% | +$91.2K |
|
5263
Boston Omaha
BOC
$438M
| $150K | ﹤0.01% |
6,468
+4,767
| +280% | +$118K |
|
5264
Harvard Bioscience
HBIO
$28.9M
| $150K | ﹤0.01% |
7,512
+6,378
| +562% | +$187K |
|
5265
Orrstown Financial Services
ORRF
$851M
| $150K | ﹤0.01% |
6,815
+3,392
| +99% | +$70K |
|
|
HABT
5266
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $150K | ﹤0.01% |
14,358
+5,352
| +59% | +$58.2K |
|
|
AVEO
5267
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $150K | ﹤0.01% |
22,236
+19,207
| +634% | +$165K |
|
|
ARQL
5268
CALL
DELISTED
Arqule Inc
ARQL
| $150K | ﹤0.01% |
+13,600
| New | +$94.7K |
|
|
CIM
5269
CALL
Chimera Investment
CIM
$982M
| $149K | ﹤0.01% |
2,633
+533
| +25% | +$30.2K |
|
5270
PUT
Trimble
TRMB
$13.6B
| $149K | ﹤0.01% |
3,300
+2,800
| +560% | +$116K |
|
|
BEDU
5271
DELISTED
Bright Scholar Education Holdings
BEDU
| $148K | ﹤0.01% |
4,074
-1,755
| -30% | -$74.4K |
|
5272
PUT
Compass Minerals
CMP
$1.26B
| $148K | ﹤0.01% |
2,700
-800
| -23% | -$44.2K |
|
5273
CALL
Cedar Fair
FUN
$1.88B
| $148K | ﹤0.01% |
3,100
-1,100
| -26% | -$57K |
|
5274
CALL
NRG Energy
NRG
$25.7B
| $148K | ﹤0.01% |
4,200
-2,000
| -32% | -$75.4K |
|
5275
Oramed Pharmaceuticals
ORMP
$180M
| $148K | ﹤0.01% |
41,186
| – | – |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.